![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Epidemiologic Impact of Expanding Chronic Hepatitis C (CHC) Treatment in People Who Inject Drug in the United States: A Mathematical Model Using Data From the C-EDGE CO-STAR Study
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting 2017; Washington, DC, USA; October 20-24, 2017.
Yiling Jiang1; Chizoba Nwankwo2
1Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire, UK;
2Merck & Co., Inc., Kenilworth, NJ, USA
![1023171](../images/102317/102317-6/1023171.gif)
![1023172](../images/102317/102317-6/1023172.gif)
![1023173](../images/102317/102317-6/1023173.gif)
![1023174](../images/102317/102317-6/1023174.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|